Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Assets (2020 - 2025)

Historic Return on Assets for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.14%.

  • Harmony Biosciences Holdings' Return on Assets rose 100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.13% for FY2024, which is 300.0% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Return on Assets stood at 0.14% for Q3 2025, which was up 100.0% from 0.14% recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Return on Assets high stood at 0.28% for Q4 2022, and its period low was 0.02% during Q1 2021.
  • Its 5-year average for Return on Assets is 0.14%, with a median of 0.12% in 2024.
  • In the last 5 years, Harmony Biosciences Holdings' Return on Assets surged by 2300bps in 2022 and then crashed by -1500bps in 2024.
  • Harmony Biosciences Holdings' Return on Assets (Quarter) stood at 0.08% in 2021, then surged by 267bps to 0.28% in 2022, then crashed by -47bps to 0.15% in 2023, then fell by -16bps to 0.12% in 2024, then grew by 12bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.14% for Q2 2025, and 0.12% during Q1 2025.